NAOV — NanoVibronix Balance Sheet
0.000.00%
- $3.26m
- $2.51m
- $2.56m
- 32
- 24
- 31
- 18
Annual balance sheet for NanoVibronix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 7.14 | 7.74 | 2.71 | 3.28 | 0.752 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.093 | 0.264 | 0.109 | 0.425 | 0.268 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7.97 | 8.34 | 5.61 | 6.49 | 3.33 |
Net Property, Plant And Equipment | 0.035 | 0.054 | 0.088 | 0.012 | 0.125 |
Other Long Term Assets | |||||
Total Assets | 8.23 | 8.62 | 5.88 | 6.67 | 3.63 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.9 | 1.9 | 2.32 | 2.45 | 2.72 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.83 | 2.31 | 2.65 | 2.69 | 3 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.39 | 6.31 | 3.23 | 3.99 | 0.627 |
Total Liabilities & Shareholders' Equity | 8.23 | 8.62 | 5.88 | 6.67 | 3.63 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |